A multidisciplinary approach to understanding skeletal dysplasias

References

• Warman ML, Cormier-Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am. J. Med. Genet. A155, 943–968 (2011).
   Web of Science ®Google Scholar
• Stoll C, Dott B, Roth MP, Alembik Y. Birth prevalence rates of skeletal dysplasias. Clin. Genet.35(2), 88–92 (1989).
   PubMed Web of Science ®Google Scholar
• Muragaki Y, Mundlos S, Upton J, Olsen BR. Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science272(5261), 548–551 (1996).
   PubMedGoogle Scholar
• Shiang R, Thompson LM, Zhu YZ et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell78(2), 335–342 (1994).
   PubMed Web of Science ®Google Scholar
• DeLise AM, Fischer L, Tuan RS. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage8(5), 309–334 (2000).
   PubMed Web of Science ®Google Scholar
• Tickle C. Molecular basis of vertebrate limb patterning. Am. J. Med. Genet.112(3), 250–255 (2002).
   PubMedGoogle Scholar
• Yoon BS, Lyons KM. Multiple functions of BMPs in chondrogenesis. J. Cell. Biochem.93(1), 93–103 (2004).
   PubMed Web of Science ®Google Scholar
• Shinomura T, Kimata K, Oike Y, Maeda N, Yano S, Suzuki S. Appearance of distinct types of proteoglycan in a well-defined temporal and spatial pattern during early cartilage formation in the chick limb. Dev. Biol.103(1), 211–220 (1984).
   PubMedGoogle Scholar
• Ng LJ, Wheatley S, Muscat GE et al. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol.183(1), 108–121 (1997).
   PubMed Web of Science ®Google Scholar
• Ballock RT, O’Keefe RJ. Physiology and pathophysiology of the growth plate. Birth Defects Res. C. Embryo Today69(2), 123–143 (2003).
   PubMedGoogle Scholar
• Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science273(5275), 613–622 (1996).
   PubMed Web of Science ®Google Scholar
• Klopocki E, Hennig BP, Dathe K et al. Deletion and point mutations of PTHLH cause brachydactyly type E. Am. J. Hum. Genet.86, 434–439 (2010).
   PubMedGoogle Scholar
• Kirkpatrick TJ, Au KS, Mastrobattista JM, McCready ME, Bulman DE, Northrup H. Identification of a mutation in the Indian Hedgehog (IHH) gene causing brachydactyly type A1 and evidence for a third locus. J. Med. Genet.40(1), 42–44 (2003).
   PubMedGoogle Scholar
• Minina E, Kreschel C, Naski MC, Ornitz DM, Vortkamp A. Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev. Cell3(3), 439–449 (2002).
   PubMed Web of Science ®Google Scholar
• Enomoto H, Enomoto-Iwamoto M, Iwamoto M et al. CBFA1 is a positive regulatory factor in chondrocyte maturation. J. Biol. Chem.275(12), 8695–8702 (2000).
   PubMed Web of Science ®Google Scholar
• Mundlos S, Otto F, Mundlos C et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell89(5), 773–779 (1997).
   PubMed Web of Science ®Google Scholar
• Colnot C, Lu C, Hu D, Helms JA. Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development. Dev. Biol.269(1), 55–69 (2004).
   PubMed Web of Science ®Google Scholar
• Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med.5(6), 623–628 (1999).
   PubMed Web of Science ®Google Scholar
• Pope FM, Nicholls AC, McPheat J, Talmud P, Owen R. Collagen genes and proteins in osteogenesis imperfecta. J. Med. Genet.22(6), 466–478 (1985).
   PubMedGoogle Scholar
• Gleghorn L, Ramesar R, Beighton P, Wallis G. A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis. Am. J. Hum. Genet.77(3), 484–490 (2005).
   PubMedGoogle Scholar
• Arikawa-Hirasawa E, Wilcox WR, Le AH et al. Dyssegmental dysplasia, Silverman–Handmaker type, is caused by functional null mutations of the perlecan gene. Nat. Genet.27(4), 431–434 (2001).
   PubMed Web of Science ®Google Scholar
• Nicole S, Davoine CS, Topaloglu H et al. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz–Jampel syndrome (chondrodystrophic myotonia). Nat. Genet.26(4), 480–483 (2000).
   PubMed Web of Science ®Google Scholar
• Superti-Furga A, Bonafe L, Rimoin DL. Molecular–pathogenetic classification of genetic disorders of the skeleton. Am. J. Med. Genet.106(4), 282–293 (2001).
   PubMedGoogle Scholar
• Trotter TL, Hall JG. Health supervision for children with achondroplasia. Pediatrics116(3), 771–783 (2005).
   PubMed Web of Science ®Google Scholar
• Krakow D, Lachman RS, Rimoin DL. Guidelines for the prenatal diagnosis of fetal skeletal dysplasias. Genet. Med.11(2), 127–133 (2009).
   PubMed Web of Science ®Google Scholar
• Horton WA, Hall JG, Hecht JT. Achondroplasia. Lancet370(9582), 162–172 (2007).
   PubMed Web of Science ®Google Scholar
• Ahmed SF, Farquharson C. The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. J. Endocrinol.206(3), 249–259 (2010).
   PubMed Web of Science ®Google Scholar
• Aviezer D, Golembo M, Yayon A. Fibroblast growth factor receptor-3 as a therapeutic target for achondroplasia – genetic short limbed dwarfism. Curr. Drug Targets4(5), 353–365 (2003).
   PubMedGoogle Scholar
• Qing J, Du X, Chen Y et al. Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice. J. Clin. Invest.119(5), 1216–1229 (2009).
   PubMed Web of Science ®Google Scholar
• Yasoda A, Komatsu Y, Chusho H et al. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat. Med.10(1), 80–86 (2004).
   PubMed Web of Science ®Google Scholar
• Bartels CF, Bukulmez H, Padayatti P et al. Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am. J. Hum. Genet.75(1), 27–34 (2004).
   PubMed Web of Science ®Google Scholar
• Fujii T, Komatsu Y, Yasoda A et al. Circulating C-type natriuretic peptide (CNP) rescues chondrodysplastic CNP knockout mice from their impaired skeletal growth and early death. Endocrinology151(9), 4381–4388 (2010).
   PubMed Web of Science ®Google Scholar
• Amir LR, Everts V, Bronckers AL. Bone regeneration during distraction osteogenesis. Odontology97(2), 63–75 (2009).
   PubMed Web of Science ®Google Scholar
• Tare RS, Kanczler J, Aarvold A, Jones AM, Dunlop DG, Oreffo RO. Skeletal stem cells and bone regeneration: translational strategies from bench to clinic. Proc. Inst. Mech. Eng. H.224(12), 1455–1470 (2010).
   PubMed Web of Science ®Google Scholar